Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-emptive Pudendal Nerve Block for Pelvic Reconstructive Surgery
NCT02409498Withdrawn
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Oct 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Visual Analog Scale pain scale up to 2 weeks. Planned start Oct 2015; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02409498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02409498.